The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capodici, C.
Right arrow Articles by Weiss, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capodici, C.
Right arrow Articles by Weiss, J.

The Journal of Immunology, Vol 156, Issue 12 4789-4796, Copyright © 1996 by American Association of Immunologists


ARTICLES

Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function

C Capodici and J Weiss
Department of Microbiology, New York University School of Medicine, New York 10016, USA.

An N-terminal fragment (residues 1-199) of the 456-residue human bactericidal/permeability-increasing protein (BPI), isolated after limited proteolysis, exhibits antibacterial and LPS-neutralizing activities equal to or greater than those of holo-BPI. To assess minimal structural requirements for bioactivity, mutant species of BPI were expressed in vivo by transient transfection and in vitro by cellfree transcription/translation. BPI1-456 and BPI1-193 demonstrated the expected antibacterial and LPS-binding activities. Deletion of the N-terminal 12 residues did not diminish BPI function. However, further truncation either from the C-terminus to residue 169 (BPI1-169) or from the N-terminus (BPIdelta15-56) yielded in vitro products with little or no LPS-binding activity and in vivo products that could not be recovered from the culture medium or cellular acid extracts. The possible role of cysteine-175 (the three cysteines in human BPI are at residues 132, 135, and 175) in BPI stability/function was examined by substitution of Cys(175) with serine. Recovery of C175S BPI from extracellular medium was reduced 10-fold, and C175S BPI produced in vitro had little LPS-binding activity. Compared with wild-type holo-BPI and BPI1-193, BPI1-169, BPIdelta15-56, and C175S BPI showed increased susceptibility to cleavage by elastase in the region 1-193 (but not in the region 200-456), indicating conformational changes that may account for the loss of function. These findings suggest that the proteolytic N- terminal fragment of BPI corresponds closely to the minimum functional (antibacterial/anti-LPS) domain of BPI and that residues near both ends of this fragment are essential for structural stability and functional integrity.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Gonzalez, Y. Gueguen, D. Destoumieux-Garzon, B. Romestand, J. Fievet, M. Pugniere, F. Roquet, J.-M. Escoubas, F. Vandenbulcke, O. Levy, et al.
Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI
PNAS, November 6, 2007; 104(45): 17759 - 17764.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Lennartsson, K. Pieters, K. Vidovic, and U. Gullberg
A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow
J. Leukoc. Biol., March 1, 2005; 77(3): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
E.E. LeClair
Four Reasons to Consider a Novel Class of Innate Immune Molecules in the Oral Epithelium
J. Dent. Res., December 1, 2003; 82(12): 944 - 950.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Iovine, J. Eastvold, P. Elsbach, J. P. Weiss, and T. L. Gioannini
The Carboxyl-terminal Domain of Closely Related Endotoxin-binding Proteins Determines the Target of Protein-Lipopolysaccharide Complexes
J. Biol. Chem., March 1, 2002; 277(10): 7970 - 7978.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Schultz, J. Weiss, S. F. Carroll, and W. L. Gross
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies
J. Leukoc. Biol., April 1, 2001; 69(4): 505 - 512.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
E. Bülow, U. Gullberg, and I. Olsson
Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein
J. Leukoc. Biol., November 1, 2000; 68(5): 669 - 678.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
J. Huuskonen, G. Wohlfahrt, M. Jauhiainen, C. Ehnholm, O. Teleman, and V. M. Olkkonen
Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis
J. Lipid Res., June 1, 1999; 40(6): 1123 - 1130.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. M. Iovine, P. Elsbach, and J. Weiss
An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains
PNAS, September 30, 1997; 94(20): 10973 - 10978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. S. Tobias, K. Soldau, N. M. Iovine, P. Elsbach, and J. Weiss
Lipopolysaccharide (LPS)-binding Proteins BPI and LBP Form Different Types of Complexes with LPS
J. Biol. Chem., July 25, 1997; 272(30): 18682 - 18685.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. J. Beamer, S. F. Carroll, and D. Eisenberg
Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution
Science, June 20, 1997; 276(5320): 1861 - 1864.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.